Please assess the completion status of the following clinical trial:

Trial Title: Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria;~-Proton pump inhibitor-resistant reflux esophagitis. (Patients who have mucosal breaks (erosions, ulcers) on endoscopy)~Exclusion criteria;~* Patients with a history of hypersensitivity to any ingredients of PARIET.~* Patients on atazanavir sulfate.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Rabeprazole Sodium (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).